These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2591407)

  • 1. Pharmacokinetics of intra-arterial indomethacin treatment for patent ductus arteriosus.
    Weninger M; Pollak A; Salzer-Muhar U; Vergesslich KA; Salzer HR
    Eur J Pediatr; 1989 Nov; 149(2):138-40. PubMed ID: 2591407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects in the treatment of patent ductus arteriosus in premature newborns with respiratory insufficiency].
    Weninger M; Pollak A; Salzer-Muhar U; Simbruner G; Salzer HR; Rosenkranz M
    Z Geburtshilfe Perinatol; 1989; 193(5):226-9. PubMed ID: 2815899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of the patent ductus arteriosus to indomethacin treatment.
    Ramsay JM; Murphy DJ; Vick GW; Courtney JT; Garcia-Prats JA; Huhta JC
    Am J Dis Child; 1987 Mar; 141(3):294-7. PubMed ID: 3812411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin pharmacokinetics in neonates: the value of volume of distribution as a marker of permanent patent ductus arteriosus closure.
    Gal P; Ransom JL; Weaver RL; Schall S; Wyble LE; Carlos RQ; Brown Y
    Ther Drug Monit; 1991 Jan; 13(1):42-5. PubMed ID: 2057990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus.
    Evans M; Bhat R; Vidyasagar D; Patel M; Hastreiter A
    Pediatr Pharmacol (New York); 1981; 1(3):251-8. PubMed ID: 7346745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin and the preterm infant with a patent ductus arteriosus: relationship between plasma concentration and ductus closure.
    Friedman CA; Parks BR; Rawson JE; Serwer GA; Anderson PA
    Dev Pharmacol Ther; 1982; 4(1-2):37-46. PubMed ID: 7117089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus.
    Wiest DB; Pinson JB; Gal PS; Brundage RC; Schall S; Ransom JL; Weaver RL; Purohit D; Brown Y
    Clin Pharmacol Ther; 1991 May; 49(5):550-7. PubMed ID: 2029829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined noninvasive assessment of the patent ductus arteriosus in the preterm infant before and after indomethacin treatment.
    Smallhorn JF; Gow R; Olley PM; Freedom RM; Swyer PR; Perlman M; Rowe RD
    Am J Cardiol; 1984 Dec; 54(10):1300-4. PubMed ID: 6507302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG; Harvey DP; Maxwell GM
    Aust Paediatr J; 1985 Aug; 21(3):181-3. PubMed ID: 4062716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants.
    Lemmers PM; Toet MC; van Bel F
    Pediatrics; 2008 Jan; 121(1):142-7. PubMed ID: 18166568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.